Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Archives of virology - 1 Jan 1996

Kirkwood C D, Bishop R F, Coulson B S

Abstract excerpt

The neutralization epitopes of human rotavirus VP4 were studied by using a panel of neutralization monoclonal antibodies previously shown to be strain-specific (RV-3:3), serotype-specific (RV-5:2, ST-3:3) or cross-reactive (F45:4). Antigenic variants of human rotaviruses RV-3, ST-3, RV-5 and F45 resistant to neutralization by the appropriate of VP4 specific monoclonal antibodies (RV-3:3, ST-3:3, RV-5:2 and F45:4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Antibodies, Monoclonal
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Line

Share to Genetic Variation

Share to Molecular Sequence Data

Share to Polymorphism, Single-Stranded Conformational

Share to Serotyping

Source

Identifiers

PMID: 8645097
DOI: 10.1007/BF01718319

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.PMID 8645097Read ↗

Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.Semantic proximity Read ↗

Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4.Semantic proximity Read ↗

Characteristics and Location of Cross-Reactive and Serotype-Specific Neutralization Sites on VP7 of Human G Type 9 RotavirusesSemantic proximity Read ↗

Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.Semantic proximity Read ↗

Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 proteinSemantic proximity Read ↗

A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection.Semantic proximity Read ↗

Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.Semantic proximity Read ↗

Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.Semantic proximity Read ↗

Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotypeSemantic proximity Read ↗

Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.Semantic proximity Read ↗

Characterization of neutralization specificities of outer capsid spike protein VP4 of selected murine, lapine, and human rotavirus strains.Semantic proximity Read ↗

Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotavirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.